SUSD2-IL-2 receptor interaction hinders antitumoral CD8+ T-cell activity: Implications for cancer immunotherapy

Allergy. 2023 Nov;78(11):3035-3037. doi: 10.1111/all.15804. Epub 2023 Jul 4.
No abstract available

Keywords: CAR T cells; CD8+ T cells; IL-2; SUSD2; cancer immunotherapy.

Publication types

  • News
  • Research Support, Non-U.S. Gov't

MeSH terms

  • CD8-Positive T-Lymphocytes
  • Humans
  • Immunotherapy
  • Immunotherapy, Adoptive
  • Membrane Glycoproteins
  • Neoplasms* / therapy
  • Receptors, Interleukin-2*

Substances

  • Receptors, Interleukin-2
  • SUSD2 protein, human
  • Membrane Glycoproteins